Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Roos I, Sharmin S, Horakova D, Kubala Havrdova E, Libertinova J, Vachova M, Alroughani R, Boz C, Rous Z, Buzzard K, et al.

J Neurol Neurosurg Psychiatry. 2026 May 20. PMID: 42161588. Abstract